IOI Corporation Berhad (KLSE:IOICORP)
Malaysia · Delayed Price · Currency is MYR | Market Cap | 23.45B |
| Revenue (ttm) | 10.91B |
| Net Income (ttm) | 1.43B |
| Shares Out | 6.20B |
| EPS (ttm) | 0.23 |
| PE Ratio | 16.39 |
| Forward PE | 17.70 |
| Dividend | 0.10 (2.65%) |
| Ex-Dividend Date | Mar 11, 2025 |
| Volume | 965,600 |
| Average Volume | 942,655 |
| Open | 3.730 |
| Previous Close | 3.730 |
| Day's Range | 3.720 - 3.780 |
| 52-Week Range | 3.420 - 4.080 |
| Beta | 0.07 |
| RSI | 52.15 |
| Earnings Date | Aug 28, 2025 |
About Ligand Pharmaceuticals
IOI Corporation Berhad, an investment holding company, primarily engages in the plantation business in Malaysia, Europe, North America, Asia, and internationally. The company operates through two segments, Plantation and Resource-Based Manufacturing. It cultivates oil palm, softwood timber, rubber, and coconut; refines and processes crude palm, crude coconut, and palm kernel oils; and manufactures specialty oils and fats. The company also manufactures and exports fatty acids, soap noodles, glycerin, fatty esters, and other related products. In ... [Read more]
Financial Performance
In 2024, IOI Corporation Berhad's revenue was 9.60 billion, a decrease of -17.09% compared to the previous year's 11.58 billion. Earnings were 1.11 billion, a decrease of -0.43%.
Financial StatementsNews
We're able to 'carve a competitive path' using the China Plus One strategy: IOI CEO
Lee Yeow Chor, CEO of IOI Corporation, says he is positive the palm oil-producing company won't be negatively affected by rising geopolitical tensions.